AAAAAA

   
Results: 1-25 | 26-36 |
Results: 26-36/36
ELEVATION OF TOPOISOMERASE-I MESSENGER-RNA, PROTEIN, AND CATALYTIC ACTIVITY IN HUMAN TUMORS - DEMONSTRATION OF TUMOR-TYPE SPECIFICITY AND IMPLICATIONS FOR CANCER-CHEMOTHERAPY
Authors: HUSAIN I MOHLER JL SEIGLER HF BESTERMAN JM
Citation: I. Husain et al., ELEVATION OF TOPOISOMERASE-I MESSENGER-RNA, PROTEIN, AND CATALYTIC ACTIVITY IN HUMAN TUMORS - DEMONSTRATION OF TUMOR-TYPE SPECIFICITY AND IMPLICATIONS FOR CANCER-CHEMOTHERAPY, Cancer research, 54(2), 1994, pp. 539-546
SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - A MULTIVARIATE-ANALYSIS OF 6383 PATIENTS EXPLORING THE SIGNIFICANCE OF GENDER IN PROGNOSTICOUTCOME
Authors: STIDHAM KR JOHNSON JL SEIGLER HF
Citation: Kr. Stidham et al., SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - A MULTIVARIATE-ANALYSIS OF 6383 PATIENTS EXPLORING THE SIGNIFICANCE OF GENDER IN PROGNOSTICOUTCOME, Archives of surgery, 129(3), 1994, pp. 316-324
SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - REPLY
Authors: STIDHAM KR JOHNSON JL SEIGLER HF
Citation: Kr. Stidham et al., SURVIVAL SUPERIORITY OF FEMALES WITH MELANOMA - REPLY, Archives of surgery, 129(12), 1994, pp. 1343-1344
THE ORDERLY PROGRESSION OF MELANOMA NODAL METASTASES
Authors: REINTGEN D CRUSE CW WELLS K BERMAN C FENSKE N GLASS F SCHROER K HELLER R ROSS M LYMAN G COX C RAPPAPORT D SEIGLER HF BALCH C
Citation: D. Reintgen et al., THE ORDERLY PROGRESSION OF MELANOMA NODAL METASTASES, Annals of surgery, 220(6), 1994, pp. 759-767
SURGICAL-MANAGEMENT OF REGIONAL LYMPH-NODES IN PATIENTS WITH MELANOMA- EXPERIENCE WITH 4682 PATIENTS
Authors: SLINGLUFF CL STIDHAM KR RICCI WM STANLEY WE SEIGLER HF
Citation: Cl. Slingluff et al., SURGICAL-MANAGEMENT OF REGIONAL LYMPH-NODES IN PATIENTS WITH MELANOMA- EXPERIENCE WITH 4682 PATIENTS, Annals of surgery, 219(2), 1994, pp. 120-130
PREVENTION AND EARLY DETECTION OF MELANOMA - A SURGEONS PERSPECTIVE
Authors: REINTGEN D ROSS M BLAND K SEIGLER HF BALCH C
Citation: D. Reintgen et al., PREVENTION AND EARLY DETECTION OF MELANOMA - A SURGEONS PERSPECTIVE, Seminars in surgical oncology, 9(3), 1993, pp. 174-187
POSSIBILITIES OF IMMUNOTHERAPY AND GENE-THERAPY FOR MALIGNANT-MELANOMA
Authors: CROWLEY NJ SEIGLER HF
Citation: Nj. Crowley et Hf. Seigler, POSSIBILITIES OF IMMUNOTHERAPY AND GENE-THERAPY FOR MALIGNANT-MELANOMA, Seminars in surgical oncology, 9(3), 1993, pp. 273-278
RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT AS ADJUVANT THERAPY FOR HIGH-RISK, MULTI-NODE-POSITIVE MALIGNANT-MELANOMA
Authors: MEISENBERG BR ROSS M VREDENBURGH JJ JONES R SHPALL EJ SEIGLER HF CONIGLIO DM WU K PETERS WP
Citation: Br. Meisenberg et al., RANDOMIZED TRIAL OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT AS ADJUVANT THERAPY FOR HIGH-RISK, MULTI-NODE-POSITIVE MALIGNANT-MELANOMA, Journal of the National Cancer Institute, 85(13), 1993, pp. 1080-1085
CELL-SURFACE REACTIVE HUMAN MONOCLONAL-ANTIBODY DIRECTED TO HUMAN MELANOMA-ASSOCIATED GANGLIOSIDES
Authors: ABDELWAHAB Z LI WP DARROW T NUDELMAN ED TOWELL A SEIGLER HF
Citation: Z. Abdelwahab et al., CELL-SURFACE REACTIVE HUMAN MONOCLONAL-ANTIBODY DIRECTED TO HUMAN MELANOMA-ASSOCIATED GANGLIOSIDES, Melanoma research, 3(6), 1993, pp. 415-423
LENTIGO-MALIGNA MELANOMA OF THE HEAD AND NECK
Authors: LANGFORD FPJ FISHER SR MOLTER DW SEIGLER HF
Citation: Fpj. Langford et al., LENTIGO-MALIGNA MELANOMA OF THE HEAD AND NECK, The Laryngoscope, 103(5), 1993, pp. 520-524
CURED FRACTION AND SURVIVAL-TIME AS FUNCTIONS OF THICKNESS, SITE, HISTOLOGIC TYPE, AGE, AND SEX
Authors: GAMEL JW GEORGE SL STANLEY WE SEIGLER HF
Citation: Jw. Gamel et al., CURED FRACTION AND SURVIVAL-TIME AS FUNCTIONS OF THICKNESS, SITE, HISTOLOGIC TYPE, AGE, AND SEX, Cancer, 72(4), 1993, pp. 1219-1223
Risultati: 1-25 | 26-36 |